Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy-Reference-Cited by-同舟云学术

Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy

Published:2018-02 Issue: Volume:37 Page:181-186
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Rakovitch Eileen,Nofech-Mozes Sharon,Hanna Wedad,Sutradhar Rinku,Gu Sumei,Fong Cindy,Tuck Alan,Youngson Bruce,Miller Naomi,Done Susan J.,Chang Martin C.,Sengupta Sandip,Elavathil Leela,Jani Prashant A.,Bonin Michel,Lalani Nafisha,Paszat Lawrence

Funder

Ontario Ministry of Health and Long-Term Care

Canadian Cancer Society Research Institute

Ontario Institute for Cancer Research

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference20 articles.

1. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17;Fisher;J Clin Oncol,1998

2. Effect of Radiation therapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial;Wärnberg;J Clin Oncol,2014

3. Radiation therapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial;Houghton;Lancet,2003

4. Breast conserving treatment with or without radiation therapy in ductal carcinoma in situ: 15 year recurrence rates and outcome after a recurrence, from the EORTC randomized phase III trial;Donker;J Clin Oncol,2013

5. Overview of the randomized trials of radiation therapy in ductal carcinoma in situ of the breast;Correa;J Natl Cancer Inst Monogr,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?;Current Oncology;2023-06-13

2. Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression;Journal of Mammary Gland Biology and Neoplasia;2022-03

3. Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ;Journal of Clinical Oncology;2021-07-20

4. Ductal carcinoma in situ (DCIS)—precision medicine for de-escalation;Current Breast Cancer Reports;2021-04-22

5. The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution;Cancer Control;2021-01-01